Rapid antigenic evolution in an influenza virus increases the likelihood of emergence of novel strains. Under the circumstances, if vaccines are not yet available, treatment plays a crucial role in control of the disease. In this meta-analysis, the authors have compared the efficacy and safety of Lianhuaqingwen capsule (LHQW-C) and oseltamivir in treating influenza A virus infection. By Pan Zhao MD et al, published in Alternative Therapies, Vol. 20, No. 2.
The immune response to influenza vaccine is attenuated in elderly persons, though they are at greatest risk for morbidity and mortality by influenza virus infection. Experimental studies demonstrate that co-administration of L-cystine and L-theanine enhanced antigen-specific production of immunoglobulin in aged mice infected with influenza virus. This study thus investigated the effect of L-cystine and L-theanine on antibody induction by influenza vaccines in elderly persons. By Koichi Miyagawa, Yoshimitsu Hayashi, Shigekazu Kurihara and Akiko Maeda, published in Geriatrics Gerentology Int’l., Japan Geriatrics Society, Vol. 8.
NEWS McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. “It’s a discovery that offers exciting new avenues for controlling influenza, since untilRead